Announcements Trials
Browse Landscape

Status

Active not recruiting 4Recruiting 3Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rare Tumour 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 35Pemetrexed 28Cisplatin 23Drug Therapy 22osimertinib 18aflutinib 11Paclitaxel 11tislelizumab 10pembrolizumab 10Surgical Procedures, Operative 10Docetaxel 10Radiotherapy 8Magnetic Resonance Spectroscopy 8anlotinib 7Specimen Handling 7Bevacizumab 7130-nm albumin-bound paclitaxel 7toripalimab 6cemiplimab 6Immunotherapy 6sintilimab 5ensartinib 5durvalumab 5Radiosurgery 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Injections 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × entrectinib × Clear all
NCT06694129 2024-11-19

Real-world Observational Study of Targeted Therapy in Patients With Advanced ROS1-positive NSCLC

National Cancer Center, China

Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡